Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0XQ8P
|
|||
Former ID |
DNC011972
|
|||
Drug Name |
2-Thiazol-5-ylmethyl-1,2-dihydro-indazol-3-one
|
|||
Synonyms |
2-(Thiazol-5-ylmethyl)-1H-indazol-3(2H)-one; 120273-62-3; CHEMBL3144715; 1,2-dihydro-2-(5-thiazolylmethyl)-3H-indazol-3-one; 2-Thiazol-5-ylmethyl-1,2-dihydro-indazol-3-one; CHEMBL267524; SCHEMBL16160907; BDBM50008996; ZINC100161259; AKOS022188370; AJ-64420; AJ-64421; AX8285840
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
![]() |
Download2D MOL |
||
Formula |
C11H9N3OS
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)C(=O)N(N2)CC3=CN=CS3
|
|||
InChI |
1S/C11H9N3OS/c15-11-9-3-1-2-4-10(9)13-14(11)6-8-5-12-7-16-8/h1-5,7,13H,6H2
|
|||
InChIKey |
KPXSUQVYEHMEMW-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Arachidonate 5-lipoxygenase (5-LOX) | Target Info | Inhibitor | [1] |
BioCyc | Aspirin-triggered lipoxin biosynthesis | |||
Resolvin D biosynthesis | ||||
Leukotriene biosynthesis | ||||
Lipoxin biosynthesis | ||||
Aspirin triggered resolvin D biosynthesis | ||||
Aspirin triggered resolvin E biosynthesis | ||||
KEGG Pathway | Arachidonic acid metabolism | |||
Metabolic pathways | ||||
Serotonergic synapse | ||||
Ovarian steroidogenesis | ||||
Toxoplasmosis | ||||
NetPath Pathway | IL4 Signaling Pathway | |||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
WikiPathways | Vitamin D Receptor Pathway | |||
Arachidonic acid metabolism | ||||
Eicosanoid Synthesis | ||||
Selenium Micronutrient Network |
References | Top | |||
---|---|---|---|---|
REF 1 | Indazolinones, a new series of redox-active 5-lipoxygenase inhibitors with built-in selectivity and oral activity. J Med Chem. 1991 Mar;34(3):1028-36. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.